Member Info for Pharmhall

GDR has failed to deliver for many years, never getting close to forecasts, and that simply does not look set to change. Promised a £1m order on Indian regulatory approval. The order simply has not happened even after approval. Dropped the AIHL statement into market two weeks ago to try and boost share price ahead of this Placing. Talking about AIHL being a £5m UK opportunity – well that will not change anything! AVOID. Simply putting your cash into managements undeserving pockets.

Oh dear, yet again. Today's positive statement is to deflect attention that GDR failed to get that £1m contract over the line. For fifth year in a row management has failed to meet ever lowered targets. Even its broker (FinnCap) will not put out a forecast for year just ended. Auditors unlikely to sign off that it has 12 months working capital, so yet another fund raise in prospect. It would have to be very deeply discounted.

Expected to be about $6,000 p.a.

Do not get hung up on this white label contract. TRX is contractually prevented from disclosing who it is, so it will not be announced. Focus on the strong demand for it products and the increased capacity coming on stream to satisfy that demand.

While I agree with you that it is good to be cynical, I cannot agree with your comment today regarding the share price movement. The shares have been very stable for over one month and were modestly down yesterday. The movement today is attributable solely to the 1H trading statement released at 7.00am, which stated that sales are up 11% and PBT will be £6m, way ahead of market expectations. Its broker has a PBT forecast for 2021 of £8.9m. Given that the outlook statement is very positive, this forecast looks very low, hence the share price movement. This is not insider movement before an announcement.